Form 4: Ginkgo Bioworks Executive Steven P. Coen Reports Stock Transactions

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units to cover tax obligations.

Summary

• On September 11 and 12, 2024, Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., engaged in transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
• On September 11, 2024, Coen acquired 587 and 156 shares of Class A Common Stock through the vesting of RSUs.
• Also on September 11, 2024, Coen disposed of 587 and 156 Restricted Stock Units.
• On September 12, 2024, Coen sold 316 shares of Class A Common Stock at a price of $6.172 per share.
• These sales were to cover tax withholding obligations related to the vesting of restricted stock and/or restricted stock units and do not represent discretionary trades.
• Following these transactions, Coen directly owns 5,609 shares of Class A Common Stock and 18,797 and 6,563 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the transactions of key personnel.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small number of shares involved.

Key Dates